Skip to content

Design, synthesis, and evaluation of chromone-triazole-thioether-benzoxazole hybrids as anti-diabetic and anti-oxidant agents with in silico, docking, simulation and DFT studies.

Oct 2026 · Bioorganic & Medicinal Chemistry · Vol 144, pp. 118838 · 0 citations · 24 references
Medicine

Abstract

Type 2 diabetes mellitus (T2DM) is a metabolic disorder associated with persistent hyperglycemia and impaired glucose regulation. Inhibition of pancreatic α-amylase is an important approach for reducing carbohydrate digestion and controlling postprandial blood glucose levels. In this study, a new series of substituted chromone-triazole-thioether-benzoxazole hybrid derivatives was designed and synthesized, and evaluated for their α-amylase inhibitory and antioxidant activities, supported by molecular docking and in silico ADMET and DFT studies. Docking studies identified 9 k as the most promising compound, with a CDOCKER interaction energy of -9.3 kcal/mol, compared with -8.6 kcal/mol for acarbose and - 8.4 kcal/mol for myricetin. Further molecular dynamics simulations and DFT studies were performed, which revealed the stability of 9 k complexes with α-amylase. The in vitro α-amylase assay showed that all compounds exhibited concentration-dependent inhibition. Among them, 9 k was the most potent inhibitor, with an IC50 value of 0.41 μg/mL, 0.98 μM, followed by 9 h (1.95 μg/mL, 4.15 μM), 9 l (2.89 μg/mL, 6.43 μM), 9n (3.25 μg/mL, 7.14 μM), and 9i (4.70 μg/mL, 11.62 μM). These compounds showed considerably stronger inhibition than the reference drug acarbose (IC₅₀ = 27.61 μg/mL, 42.77 μM). In the DPPH assay, 9 g showed the strongest radical-scavenging activity (IC₅₀ = 0.05 μg/mL, 0.11 μM), followed by 9a (0.62 μg/mL, 1.59 μM), 9i (1.34 μg/mL, 3.31 μM), and 9n (2.52 μg/mL, 5.54 μM). In silico ADME analysis indicated that most of the synthesized derivatives possessed acceptable drug-like and pharmacokinetic properties. Toxicity prediction further suggested a favorable safety profile. Overall, the combined biological and computational findings identified 9 k, and 9n as the most promising compounds, which may act as lead candidates for further development of novel antidiabetic agents.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.